A total of 345 faecal samples were collected from domestic, captive and wild birds in rural areas, urban areas and a Zoo in Algeria. Samples were screened for the presence of parasites belonging to the genus Cryptosporidium Tyzzer, 1910 by microscopy and PCR analysis of the small-subunit rRNA (SSU), actin and 60-kDa glycoprotein (gp60) genes. Cryptosporidium spp. were detected in 31 samples. Sequence analysis of SSU and actin genes revealed the presence of C. baileyi Current, Upton et Haynes, 1986 in domestic chicken broilers (n = 12), captive ostriches (n = 4) and a wild mallard (n = 1), and C. meleagridis Slavin, 1955 in a graylag goose (n = 1), chickens (n = 11) and turkeys (n = 2). Twenty-three chicken and two turkey broilers from five farms were positive for cryptosporidia, with an overall prevalence of 2% and 6%, respectively. Both C. meleagridis and C. baileyi were detected in farmed chicken broilers, with a prevalence ranging from 9% to 69%. Farmed turkeys broilers were positive only for C. meleagridis, with a 13% prevalence at the animal level. Subtyping of C. meleagridis isolates at the gp60 locus showed the presence of subtype IIIgA22G3R1 in graylag goose and chicken broilers and IIIgA23G2R1 in chicken and turkey broilers. Infection with cryptosporidia was not associated with any clinical diseases. The results of the present study, which provides the first data on the prevalence of Cryptosporidium spp. in wild birds in Africa, demonstrate the presence of human pathogenic C. meleagridis in both domestic and wild birds in Algeria., Abd Elkarim Laatamna, Nikola Holubová, Bohumil Sak, Martin Kváč., and Obsahuje bibliografii
a1_Understanding of the diversity of species of Cryptosporidium Tyzzer, 1910 in tortoises remains incomplete due to the limited number of studies on these hosts. The aim of the present study was to characterise the genetic diversity and biology of cryptosporidia in tortoises of the family Testudinidae Batsch. Faecal samples were individually collected immediately after defecation and were screened for presence of cryptosporidia by microscopy using aniline-carbol-methyl violet staining, and by PCR amplification and sequence analysis targeting the small subunit rRNA (SSU), Cryptosporidium oocyst wall protein (COWP) and actin genes. Out of 387 faecal samples from 16 tortoise species belonging to 11 genera, 10 and 46 were positive for cryptosporidia by microscopy and PCR, respectively. All samples positive by microscopy were also PCR positive. Sequence analysis of amplified genes revealed the presence of the Cryptosporidium tortoise genotype I (n = 22), C. ducismarci Traversa, 2010 (n = 23) and tortoise genotype III (n = 1). Phylogenetic analyses of SSU, COWP and actin gene sequences revealed that Cryptosporidium tortoise genotype I and C. ducismarci are genetically distinct from previously described species of Cryptosporidium. Oocysts of Cryptosporidium tortoise genotype I, measuring 5.8-6.9 µm × 5.3-6.5 µm, are morphologically distinguishable from C. ducismarci, measuring 4.4-5.4 µm × 4.3-5.3 µm. Oocysts of Cryptosporidium tortoise genotype I and C. ducismarci obtained from naturally infected Russian tortoises (Testudo horsfieldii Gray) were infectious for the same tortoise but not for Reeve's turtles (Mauremys reevesii [Gray]), common garter snake (Thamnophis sirtalis [Linnaeus]), zebra finches (Taeniopygia guttata [Vieillot]) and SCID mice (Mus musculus Linnaeus)., a2_The prepatent period was 11 and 6 days post infection (DPI) for Cryptosporidium tortoise genotype I and C. ducismarci, respectively; the patent period was longer than 200 days for both cryptosporidia. Naturally or experimentally infected tortoises showed no clinical signs of disease. Our morphological, genetic, and biological data support the establishment of Cryptosporidium tortoise genotype I as a new species, Cryptosporidium testudinis sp. n., and confirm the validity of C. ducismarci as a separate species of the genus Cryptosporidium., Jana Ježková, Michaela Horčičková, Lenka Hlásková, Bohumil Sak, Dana Květoňová, Jan Novák, Lada Hofmannová, John McEvoy, Martin Kváč., and Obsahuje bibliografii
pořádají Česká společnost intervenční radiologie ČLS JEP, Radiologická klinika 2. LF UK a FN Motol Praha, Radiodiagnostické oddělení nemocnice Karlovy Vary
Trend odkládání reprodukce vede k vyššímu procentu plánovaných početí. To umožňuje prekoncepční intervenci. Nejlépe dokumentován je význam podávání folátů, které snižují výskyt defektů neurální trubice, vrozených srdečních vad, vrozených vad uropoetického traktu, plodů s nižší porodní váhou, patologií placenty a spontánních potratů. Suplementaci foláty minimálně měsíc před otěhotněním a v 1. trimestru doporučuje 17 německých odborných společností. Metylfolát [(6S)-5methyltetrahydrofolát] je biologicky aktivní folát, který není závislý na aktivitě MTHFR. K dosud jediné dostupné kalciové soli (označované jako 3. generace folátu) nově přibývá glukosaminová sůl metylfolátu (4. generace folátu), charakterizovaná vyšší stabilitou, rozpustností a biologickou dostupností., The tendency of reproduction delay leads to a higher rate of planned conception. This allows preconception intervention. The importance of folate administration is well documented. Folates reduce the incidence of neural tube defects, congenital heart defects, congenital anomalies of urinary tract, foetuses with lower birth weight, placental pathology and spontaneous abortion. Seventeen German professional societies recommend folate supplementation for at least one month before pregnancy and in the first trimester. Methylfolate [(6S) -5methyltetrahydrofolic acid] is the biologically active folate which is not dependent on the activity of MTHFR. Recently, glucosamine salt of methylfolate (folate of 4th generation) has been introduced and is characterized by greater stability, solubility and bioavalability in comparison to known calcium salts (folate of 3rd generation)., and Tomáš Fait